Details for New Drug Application (NDA): 050782
✉ Email this page to a colleague
The generic ingredient in CLINDAGEL is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
Summary for 050782
| Tradename: | CLINDAGEL |
| Applicant: | Bausch |
| Ingredient: | clindamycin phosphate |
| Patents: | 0 |
Pharmacology for NDA: 050782
| Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 050782
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLINDAGEL | clindamycin phosphate | GEL;TOPICAL | 050782 | NDA | Bausch Health US, LLC | 16781-462 | 16781-462-06 | 6 BOTTLE in 1 CARTON (16781-462-06) / 7.3 mL in 1 BOTTLE |
| CLINDAGEL | clindamycin phosphate | GEL;TOPICAL | 050782 | NDA | Bausch Health US, LLC | 16781-462 | 16781-462-75 | 1 BOTTLE in 1 CARTON (16781-462-75) / 75 mL in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TOPICAL | Strength | EQ 1% BASE | ||||
| Approval Date: | Nov 27, 2000 | TE: | AB2 | RLD: | Yes | ||||
Expired US Patents for NDA 050782
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch | CLINDAGEL | clindamycin phosphate | GEL;TOPICAL | 050782-001 | Nov 27, 2000 | 6,387,383 | ⤷ Get Started Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
